SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-330139
Filing Date
2021-11-15
Accepted
2021-11-15 17:17:12
Documents
20
Period of Report
2021-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d243256d8k.htm   iXBRL 8-K 33906
2 EX-4.1 d243256dex41.htm EX-4.1 72890
3 EX-4.2 d243256dex42.htm EX-4.2 75038
4 EX-5.1 d243256dex51.htm EX-5.1 16563
5 EX-10.1 d243256dex101.htm EX-10.1 137846
6 EX-99.1 d243256dex991.htm EX-99.1 12703
10 GRAPHIC g243256dsp34.jpg GRAPHIC 2629
11 GRAPHIC g243256g1115104119553.jpg GRAPHIC 2787
12 GRAPHIC g243256g1115105148306.jpg GRAPHIC 4872
  Complete submission text file 0001193125-21-330139.txt   586133

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tcda-20211112.xsd EX-101.SCH 2889
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcda-20211112_lab.xml EX-101.LAB 18139
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcda-20211112_pre.xml EX-101.PRE 11406
13 EXTRACTED XBRL INSTANCE DOCUMENT d243256d8k_htm.xml XML 3360
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 211412473
SIC: 2834 Pharmaceutical Preparations